1. Home
  2. BRTX vs SSKN Comparison

BRTX vs SSKN Comparison

Compare BRTX & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • SSKN
  • Stock Information
  • Founded
  • BRTX 1997
  • SSKN 1989
  • Country
  • BRTX United States
  • SSKN United States
  • Employees
  • BRTX N/A
  • SSKN N/A
  • Industry
  • BRTX Managed Health Care
  • SSKN Medical/Dental Instruments
  • Sector
  • BRTX Health Care
  • SSKN Health Care
  • Exchange
  • BRTX Nasdaq
  • SSKN Nasdaq
  • Market Cap
  • BRTX 11.3M
  • SSKN 12.5M
  • IPO Year
  • BRTX N/A
  • SSKN 2005
  • Fundamental
  • Price
  • BRTX $1.41
  • SSKN $3.05
  • Analyst Decision
  • BRTX Strong Buy
  • SSKN
  • Analyst Count
  • BRTX 1
  • SSKN 0
  • Target Price
  • BRTX $18.00
  • SSKN N/A
  • AVG Volume (30 Days)
  • BRTX 100.5K
  • SSKN 4.7K
  • Earning Date
  • BRTX 11-12-2024
  • SSKN 11-13-2024
  • Dividend Yield
  • BRTX N/A
  • SSKN N/A
  • EPS Growth
  • BRTX N/A
  • SSKN N/A
  • EPS
  • BRTX N/A
  • SSKN N/A
  • Revenue
  • BRTX $377,000.00
  • SSKN $32,674,999.00
  • Revenue This Year
  • BRTX $482.76
  • SSKN $0.94
  • Revenue Next Year
  • BRTX $212.24
  • SSKN $11.30
  • P/E Ratio
  • BRTX N/A
  • SSKN N/A
  • Revenue Growth
  • BRTX 189.55
  • SSKN N/A
  • 52 Week Low
  • BRTX $1.03
  • SSKN $2.51
  • 52 Week High
  • BRTX $3.67
  • SSKN $6.50
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 41.13
  • SSKN 55.69
  • Support Level
  • BRTX $1.40
  • SSKN $2.96
  • Resistance Level
  • BRTX $1.60
  • SSKN $3.15
  • Average True Range (ATR)
  • BRTX 0.10
  • SSKN 0.12
  • MACD
  • BRTX 0.00
  • SSKN 0.01
  • Stochastic Oscillator
  • BRTX 42.86
  • SSKN 79.31

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.

Share on Social Networks: